M3 Inc banner

Intrinsic Value

The intrinsic value of M3 Inc (MTHRY) under the Base Case is 5.17 USD per share. Compared with the current market price of 5.8 USD, the stock appears Overvalued by 11% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

MTHRY Intrinsic Value
$5.17
Overvaluation 11%
Intrinsic Value
Price $5.8

MTHRY is valued in line with its history. A premium of this size has been typical over the past 5 years.

Monitor MTHRY
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $4.14
Get notified when the price drops into your buy zone
Current Price $5.8
Intrinsic Value $5.17
Margin of Safety 20% $4.14
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MTHRY

Fundamental Analysis

What M3 Does

Health Care

M3 Inc. is a Japan-based healthcare information company built around online services for doctors and other medical professionals. Its core business is a set of physician-focused websites and digital platforms where doctors read medical news, search reference material, exchange opinions, and access tools that help with daily clinical work. It also runs job-matching services for doctors and other healthcare workers, plus services that help pharmaceutical companies reach medical professionals.

Headquarters
Japan JP
Employees
15 360
IPO date
Sep 16, 2004
Read the full company overview
View Company Overview

M3 has no economic moat

No Moat Narrow Wide

M3 Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
M3 Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one MTHRY stock?

The intrinsic value for M3 Inc (MTHRY) under the Base Case is 5.17 USD.

Is MTHRY stock undervalued or overvalued?

Compared with the current market price of 5.8 USD, the stock appears Overvalued by 11% .

Back to Top